Stream Biomedical, Inc. Announces Acceptance of Abstract for Presentation at Annual Meeting of the American Society of Neurotherapeutics (ASENT) Conference 2025

HOUSTON, March 4, 2025 /PRNewswire/ — Stream Biomedical, Inc. (“Stream”), a clinical-stage biotechnology company developing novel solutions for acute and chronic neurodegenerative diseases, today announced acceptance of an abstract for presentation at the Annual Meeting of the American…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.